Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs032200024
JPRN-jRCTs032200024
Recruiting
Phase 1

A pilot study for chronic dialysis patients: Safety study using CV port and new needle for blood return of chronic dialysis patients

Yamagata Kunihiro0 sites5 target enrollmentApril 27, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Yamagata Kunihiro
Enrollment
5
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamagata Kunihiro

Eligibility Criteria

Inclusion Criteria

  • •1\) Chronic dialysis patients at participating institutions of this study
  • •2\) Patients who have difficulty in puncturing vascular access of arteriovenous fistula shunt, artificial graft, subcutaneously fixed superficial artery, or the autologous blood vessels, and are unable to secure an appropriate blood return, or can puncture but have insufficient blood return.
  • •3\) Men and women over 20 years old with written informed consent

Exclusion Criteria

  • •1 participant allergic to CV port
  • •2 If there is an infection at the CV port insertion site or if there is a suspicion of infection
  • •3 participant with a cardiac pacemaker or ICD (implantable cardioverter defibrillator) in progress
  • •4 participants who are judged inappropriate by the researcher
  • •5 participants whose mean blood flow in maintenance dialysis are more than 210ml / min for 1 week just before study participation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ)Dialysis related amyloidosis
JPRN-UMIN000004733beta2-microgloblin removal therapy study group600
Completed
Not Applicable
In DIAlysis patient study of efficacy and safety of MONthly minoDoronate
JPRN-UMIN000010185Oita university facility of medicine50
Completed
Not Applicable
Exploratory clinical trial of dialysis dose monitor with optical measurementEnd stage renal disease
JPRN-UMIN000011082Tokyo Women's Medical University Department of Blood Purification30
Recruiting
Not Applicable
Trial for the initiation of dialysis patients by EPA for prevention of cardiovascular event in Juntendo University Hospital
JPRN-UMIN000012150Department of Internal Medicine,Juntendo University Faculty of Medicine200
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency
EUCTR2006-003650-20-ITMerck and Co Inc.276